2022_
PÉREZ-NUÑEZ I, ROZALÉN C, PALOMEQUE JA, SANGRADOR I, DALMAU M, COMERMA L, HERNÁNDEZ-PRAT A, CASADEVALL D, MENENDEZ S, DAN LIU D, SHEN M, BERENGER J, RIUS RUIZ I, PEÑA R, MONTAÑÉS JC, ALBÀ MM, BONNIN S, PONOMARENKO J, R GOMIS R, CEJALVO JM, SERVITJA S, M MARZESE D, MOREY L, VOORWERK L, ARRIBAS J, BERMEJO B, KOK M, PUSZTAI L, KANG Y, ALBANELL J, CELIÀ-TERRASSA T*
LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer. Nature Cancer.
2021_
BERENGUER J, CELIÀ-TERRASSA T
Cell memory of epithelial-mesenchymal plasticity in cancer. Current Opinion in Cell Biology.
VON LOCQUENGHIEN M, ROZALÉN C, CELIÀ-TERRASSA T
Interferons in cancer immunoediting: sculpting metastasis and immunotherapy response. The Journal of Clinical Investigation 2021.
2019_
Celià-Terrassa T*, Jolly MK.
Cancer stem cells and epithelial-to-mesenchymal transition in cancer metastasis. Review in Cold Spring Harbor Perspectives in Medicine.
Jolly MK., Celià-Terrassa T*.
Dynamics of phenotypic heterogeneity associated with EMT and stemness during cancer progression. Review in Journal of Clinical Medicine.
Shen M, Jiang YZ, Wei Y, Ell B, Sheng X, Esposito M, Kang J, Hang X, Zheng H, Rowicki M, Zhang L, Shih WJ, Celià-Terrassa T, Liu Y, Cristea I, Shao ZM, Kang Y.
Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling. Cancer Cell.
2018_
Celià-Terrassa T*, Bastian C*, Liu D. D, Ell B, Aiello N, Wei Y, Zamalloa J, Blanco A. M, Hang X, Kunisky D, Rabitz H and Kang Y
Hysteresis control of epithelial-mesenchymal transition dynamics conveys a distinct program with enhanced metastatic ability. Nature Communications.
Celià-Terrassa T, Kang Y.
Metastatic niche functions and therapeutic opportunities. Nature Cell Biology
Chakrabarti R, Celià-Terrassa T, Kumar S, Hang X, Wei Y, Choudhury A, Hwang J, Peng J, Nixon B, Grady J, DeCoste C, Gao J, Van Es J, Li MO, Aifantis I, Clevers H, Kang Y.
Notch ligand Dll1-mediated crosstalk between mammary gland stem cells and the macrophageal niche. Science
Celià-Terrassa T
Mammary stem cells and breast cancer stem cells: molecular connections and clinical implications. (2018) May 4 Biomedicines
2017_
Celià-Terrassa T, Liu D, Choudhury A, Hang X, Wei Y, Zamalloa J, Alfaro-Aco R, Chakrabarti R, Jiang Y, Ihn Koh B, Smith H, DeCoste C, Li J, Shao Z and Kang Y.
Normal and cancer mammary stem cells evade interferon-induced constraint through the miR-199a-LCOR axis. Nature Cell Biology (Cover highlighted)
2016_
Celià-Terrassa T, Kang Y.
Distinctive properties of metastasis-initiating cells. 30(8). Genes & Development
2012_
Celià-Terrassa T, Meca-Cortés O, Mateo F, Martínez de Paz A, Rubio N, Arnal-Estapé A, Ell BJ, Bermudo R, Díaz A, Guerra-Rebollo M, Lozano JJ, Estarás C, Ulloa C, Álvarez-Simón D, Milà J, Vilella R, Paciucci R, Martínez-Balbás M, García de Herreros A, Gomis R, Kang Y, Blanco J, Fernández PL, and Thomson TM.
Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor- initiating cells. Journal of Clinical Investigation
2011_
Korpal M, Ell BJ, Buffa FM, Ibrahim T, Blanco MA, Celià-Terrassa T, Mercatali L, Khan Z, Goodarzi H, Hua Y, Wei Y, Hu G, Garcia B, Ragoussis J, Amadori D, Harris AL and Kang Y.
Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. 17:1101-1108. Nature Medicine
